These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
133 related items for PubMed ID: 7882339
21. Rat carotid arteriotomy: c-myc is involved in negative remodelling and apoptosis. De Feo M, Forte A, Onorati F, Renzulli A, Cipollaro M, Cotrufo M, Rossi F, Cascino A. J Cardiovasc Med (Hagerstown); 2006 Jan; 7(1):61-7. PubMed ID: 16645362 [Abstract] [Full Text] [Related]
22. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M. Clin Cancer Res; 2003 Oct 01; 9(12):4595-605. PubMed ID: 14555535 [Abstract] [Full Text] [Related]
23. A new molecular role for iron in regulation of cell cycling and differentiation of HL-60 human leukemia cells: iron is required for transcription of p21(WAF1/CIP1) in cells induced by phorbol myristate acetate. Gazitt Y, Reddy SV, Alcantara O, Yang J, Boldt DH. J Cell Physiol; 2001 Apr 01; 187(1):124-35. PubMed ID: 11241357 [Abstract] [Full Text] [Related]
24. Quantifying c-myc expression in c-myc antisense phosphorothioate oligodeoxynucleotide-treated leukemic and colon cancer cell lines. Li BD, Budnick RM, Russo CA, Anderson GR, Stewart CC. J Surg Res; 1995 Oct 01; 59(4):485-92. PubMed ID: 7564322 [Abstract] [Full Text] [Related]
25. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells. Bondurant MC, Yamashita T, Muta K, Krantz SB, Koury MJ. J Cell Physiol; 1996 Aug 01; 168(2):255-63. PubMed ID: 8707861 [Abstract] [Full Text] [Related]
26. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence. Zupi G, Scarsella M, Semple SC, Mottolese M, Natali PG, Leonetti C. Clin Cancer Res; 2005 Mar 01; 11(5):1990-8. PubMed ID: 15756025 [Abstract] [Full Text] [Related]
27. Antisense down-regulation of metallothionein induces growth arrest and apoptosis in human breast carcinoma cells. Abdel-Mageed A, Agrawal KC. Cancer Gene Ther; 1997 Mar 01; 4(3):199-207. PubMed ID: 9171939 [Abstract] [Full Text] [Related]
28. Effects of recombinant human transforming growth factor-beta 1 or/and interleukin-6 on growth inhibition and proto-oncogene c-myc expression in human leukemia cells. Feng R, Shen S, Hui H, Jin M. Chin Med J (Engl); 1997 Nov 01; 110(11):847-50. PubMed ID: 9772416 [Abstract] [Full Text] [Related]
29. Protein kinase A RIalpha antisense inhibition of PC3M prostate cancer cell growth: Bcl-2 hyperphosphorylation, Bax up-regulation, and Bad-hypophosphorylation. Cho YS, Kim MK, Tan L, Srivastava R, Agrawal S, Cho-Chung YS. Clin Cancer Res; 2002 Feb 01; 8(2):607-14. PubMed ID: 11839683 [Abstract] [Full Text] [Related]
30. Effects of phosphodiester and phosphorothioate antisense oligodeoxynucleotides on cell lines which overexpress c-myc: implications for the treatment of Burkitt's lymphoma. Williams SA, Gillan ER, Knoppel E, Buzby JS, Suen Y, Cairo MS. Ann Oncol; 1997 Feb 01; 8 Suppl 1():25-30. PubMed ID: 9187425 [Abstract] [Full Text] [Related]
31. Antitumor effect of c-myc antisense phosphorothioate oligodeoxynucleotides on human melanoma cells in vitro and and in mice. Leonetti C, D'Agnano I, Lozupone F, Valentini A, Geiser T, Zon G, Calabretta B, Citro G C, Zupi G. J Natl Cancer Inst; 1996 Apr 03; 88(7):419-29. PubMed ID: 8618233 [Abstract] [Full Text] [Related]
32. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. Bennett MR, Anglin S, McEwan JR, Jagoe R, Newby AC, Evan GI. J Clin Invest; 1994 Feb 03; 93(2):820-8. PubMed ID: 8113414 [Abstract] [Full Text] [Related]
33. E2F activity is essential for survival of Myc-overexpressing human cancer cells. Santoni-Rugiu E, Duro D, Farkas T, Mathiasen IS, Jäättelä M, Bartek J, Lukas J. Oncogene; 2002 Sep 19; 21(42):6498-509. PubMed ID: 12226753 [Abstract] [Full Text] [Related]
34. Reduction of cisplatin cytotoxicity on human lung cancer cell lines with N-myc amplification by pretreatment with N-myc antisense oligodeoxynucleotides. Mizushima Y, Kashii T, Kobayashi M. Anticancer Res; 1995 Sep 19; 15(1):37-43. PubMed ID: 7733638 [Abstract] [Full Text] [Related]
35. Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3. Ely CM, Leftwich JA, Chenevix-Trench G, Hall RE, Westin EH. Cancer Res; 1987 Sep 01; 47(17):4595-600. PubMed ID: 3476196 [Abstract] [Full Text] [Related]
36. Effects of tiazofurin on protooncogene expression during HL-60 cell differentiation. Kharbanda SM, Sherman ML, Spriggs DR, Kufe DW. Cancer Res; 1988 Nov 01; 48(21):5965-8. PubMed ID: 2901907 [Abstract] [Full Text] [Related]
37. Growth inhibition of SK-MEL-30 human melanoma cells by antisense c-myc oligonucleotides delivered by poly(N-isopropylacrylamide)/ poly(ethyleneimine) copolymer. Dinçer S, Oskay EK, Piskin AK, Zeybek ND, Pişkin E. J Tissue Eng Regen Med; 2010 Jun 01; 4(4):284-90. PubMed ID: 19967748 [Abstract] [Full Text] [Related]
38. Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. Reed JC, Stein C, Subasinghe C, Haldar S, Croce CM, Yum S, Cohen J. Cancer Res; 1990 Oct 15; 50(20):6565-70. PubMed ID: 2208117 [Abstract] [Full Text] [Related]
39. [Effects of c-myc antisense oligodeoxynucleotide transfected by liposome on HL-60 cells]. Chen L, Zhuo G, Chen Z. Zhonghua Nei Ke Za Zhi; 2000 Oct 15; 39(10):660-3. PubMed ID: 11374170 [Abstract] [Full Text] [Related]